Lieff Cabraser Announces Filing of Lawsuit on Behalf of Rutherford County, Tennessee Against Prescription Opioid Manufacturers

Lieff Cabraser Files Opioid Harm Lawsuit

Lawsuit Seeks to Recover Taxpayer Monies Spent Combating the Opioid Epidemic Ravaging the Rutherford County Community; Rutherford Joins Other Tennessee Counties and Cities Seeking Justice in Rising Tide of Opiate Plague

Mark Chalos, Managing Partner of the Nashville office of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Rutherford County has filed a lawsuit against prescription opioid manufacturers and distributors to recover taxpayer money spent to combat the opioid epidemic wreaking havoc on the Rutherford County community. The complaint, filed in federal court in Tennessee, alleges that the named opiate drug manufacturers and distributors and their agents deliberately and repeatedly violated federal and state law by widely and falsely promoting highly addictive opioids as safe and necessary, all the while concealing the true risks of the drugs. [Read more…]

National Opioid Epidemic is Creating Significant Costs for Government Bodies

San Francisco Opioid Lawsuit Filed

Well over 100 Americans die every day from prescription opioid drugs – over 36,000 American each year. These accidental drug overdoses are the leading cause of death for individuals under the age of 50 in the United States. The costs of this horrific opioid epidemic have crept up on local and larger government bodies much in the same way the addictions themselves sneak up on individuals. [Read more…]

Lieff Cabraser and Co-Counsel to Represent Broward County & the City of Fort Lauderdale in Opioid Litigation

Lieff Cabraser Opioid Lawsuits

Broward County and the city of Fort Lauderdale have announced that they will be represented by a team of five law firms, including Lieff Cabraser Heimann & Bernstein, in litigation against pharmaceutical companies and drug distributors for their alleged roles in the devastating and ongoing opioid crisis. The other firms on the team are Haliczer Pettis & Schwamm, Kopelowitz Ostrow Ferguson Weiselberg Gilbert, Morgan & Morgan, and Robbins Geller Rudman & Dowd. [Read more…]

Mark Chalos Speaks on Claims Issues in Opiate Crisis Lawsuits at HarrisMartin Opioid MDL Conference

Mark Chalos Speaks on Claims Issues in Opiate Crisis Lawsuits at HarrisMartin Opioid MDL Conference

Lieff Cabraser partner Mark P. Chalos will participate in a panel discussion at the HarrisMartin’s Plaintiff Opioid MDL Conference next week at the Westin Hotel in Cleveland, Ohio. Mark will speak on Monday January 8th on “Third-Party Payor, Class, and Hospital Claims” as they relate to the ongoing national opioid crisis. In December 2017, Mark and the Lieff Cabraser attorney team filed actions in Tennessee federal courts on behalf of both the city of Nashville and the government of Smith County in Middle Tennessee. Prescription opioid drugs are estimated to kill upwards of 100 Americans per day — over 36,000 Americans per year. The cases seek to hold opioid manufacturers and distributors liable for their part in creating and fostering the crisis. [Read more…]

Lieff Cabraser Files Lawsuit to Recover Taxpayer Monies from Prescription Opioid Manufacturers on Behalf of Metropolitan Government of Nashville and Davidson County, Tennessee

Lieff Cabraser Files Opioid Harm Lawsuit

Lawsuit seeks justice and restitution for Nashville’s ongoing battle against opioid crisis that has killed over 200 residents in 2017 alone

Nashville, TN—Mark P. Chalos of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announces that the Metropolitan Government of Nashville and Davidson County, Tennessee (“Nashville”), has filed a lawsuit against the manufacturers and distributors of prescription opioid drugs to recover taxpayer money and resources spent to combat the opioid epidemic wreaking havoc on the Nashville community. [Read more…]

Lieff Cabraser Files Lawsuit on Behalf of Smith County TN Against Prescription Opioid Manufacturers

Opioid Litigation

Lawsuit Seeks to Recover Taxpayer Monies Spent Combating the Opioid Epidemic Ravaging the Smith County Community; Believed to be the First Tennessee County to File Opioids Lawsuit in Federal Court

Nashville, Tennessee–(BUSINESSWIRE)–Mark P. Chalos of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP announces that Smith County has filed a lawsuit against prescription opioid manufacturers and distributors to recover taxpayer money spent to combat the opioid epidemic wreaking havoc on the Smith County community. The complaint, which is believed to be the first by a Tennessee county to be filed in federal court, alleges that the defendants in the suit, which include Purdue Pharma, Cephalon, Teva Pharmaceutical, Johnson & Johnson, Janssen Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Noramco Inc., Endo Health Solutions, Mallinckrodt, Allergan, Actavis, Watson Pharmaceuticals, Insys Therapeutics, AmerisourceBergen Drug Corporation, Cardinal Health, and additional affiliated businesses and entities (the “Defendants”), violated the law by falsely promoting highly addictive opioids as safe and necessary, while concealing the true risks of the drugs. [Read more…]

Mark Chalos Talks to Governing About America’s Lethal Opioid Crisis

Mark Chalos Talks to Governing About America's Lethal Opioid Crisis

Over 100 States and Cities Are Now Suing Drug Companies Over Pandemic Opioid Deaths and Addictions Nationwide

Governing has published a new report on the wide proliferation of lawsuits filed by cities and states against prescription drugmakers for their role in the nation’s opioid epidemic. As the platform notes, new opioid harm lawsuits are being filed almost every week. Unlike most drug epidemics, the opioid scourge is driven largely by a legal industry — the prescription drug system. The National Institute on Drug Abuse estimates that 75 percent of people who enter treatment for a heroin addiction took their first opioid legally from a prescription. [Read more…]

Lieff Cabraser Enters Into Agreement with Scott County TN to Explore Opioid Epidemic Lawsuit

Opioid epidemic reaching epic proportions

Lieff Cabraser, with Knoxville-based Taylor and Knight, has entered into an official agreement with Scott County, Tennessee, to explore litigation against pharmaceutical companies and other parties over the pernicious opioid epidemic in Scott County. The decision, first announced by WBNT News, came via a unanimous 10-0 vote by the county legislature to begin investigation into lost revenues relating to the widespread distribution and use of pharmaceutical opioids in the county. [Read more…]

$300 Million Settlement in Benicar Litigation Over Drug Injury Claims

$300 Million Settlement in Benicar Litigation Over Drug Injury Claims

A $300 million settlement has been reached in the multidistrict Benicar litigation against Daiichi Sankyo Inc. and Forest Laboratories Inc. on claims that the top-selling blood pressure drug caused severe, and sometimes life-threatening, gastrointestinal injuries in users. [Read more…]

Congressional Bill HR 1215 Will Restrict Americans’ Rights to Obtain Justice in Medical Malpractice Cases

American Healthcare issues

Congress is about to vote on a bill that could restrict the rights of all Americans to obtain justice in our court system in cases of medical malpractice, including in cases involving negligent nursing homes and defective prescription drugs and medical devices. This bill would tip the scale against injured patients and their families in favor of the insurance industry and other large corporations. [Read more…]

Lexi Hazam Named to Plaintiffs Executive Committee in Nationwide Abilify Drug Injury Litigation

Lexi Hazam Named to Plaintiffs Executive Committee in Nationwide Abilify Drug Injury Litigation

On December 16, 2016, Chief Judge M. Casey Rodgers of the U.S. District Court for the Northern District of Florida issued an order appointing Lexi J. Hazam of Lieff Cabraser to the Plaintiffs’ Executive Committee in the multidistrict litigation previously consolidated in October 2016 over injuries and financial losses sustained by patients as a result of their use of the prescription drug Abilify. [Read more…]

Bristol-Myers Squibb Pays $19.5 Million Over Improper Abilify Drug Marketing

Abilify Gambling Addiction Injuries

Bristol-Myers Squibb has agreed to pay $19.5 million to settle claims of improper advertising relating to its top-selling drug Abilify. 42 states and Washington D.C. alleged that the company improperly advertised antipsychotic drug Abilify, first approved in 2002 by the FDA to treat schizophrenic in adults. However, Bristol-Myers Squibb thereafter began promoting Abilify for off-label uses not approved by the FDA. These off-label uses had not been established as safe or effective. [Read more…]

Abilify Gambling Lawsuits Consolidated in Florida Federal Court

Abilify Gambling Lawsuits Consolidated in Florida Federal Court

The Judicial Panel on Multidistrict Litigation has consolidated more than 20 lawsuits against Bristol-Myers Squibb Co. over claims of pathological gambling side effects in patients using the antipsychotic drug Abilify in federal court in Florida. The serious impulse-control problems described in the complaints reportedly stop when the medicine is discontinued. 22 actions pending in 12 districts will be centralized under Chief District Judge M. Casey Rodgers. [Read more…]

Study Finds Majority of Parents Give Their Children Wrong Dose of Liquid Medication

Study Finds Majority of Parents Give Their Children Wrong Dose of Liquid Medication

A study by various pediatric clinics located in New York, Atlanta, and California has discovered that the majority of parents unknowingly provide their children with the wrong dosage of liquid medication. This is occurring in part because despite pediatric medicines including a measuring tool with related instructions, often the units on the label – milliliters, mL, teaspoon, tsp., tablespoon – differ from what’s on the tools themselves. [Read more…]

Upcoming FDA Public Hearing on Off-Label Drug and Device Use

Upcoming FDA Public Hearing on Off-Label Drug and Device Use

The U.S. Food and Drug Administration (FDA) has announced a public hearing forum to take place on November 9-10, 2016 with regard to the enforcement of rules relating to off-label drug and medical product use in the public health industry. The registration deadline to present at the hearing is October 19, 2016, and the deadline for written commentary after the hearing is January 9, 2017. [Read more…]

Lieff Cabraser Announces Filing of Personal Injury Lawsuit Against Bristol-Myers Squibb and Otsuka Pharmaceutical for Damages Caused by Abilify Prescription Drug

high contrast image of casino roulette

Gambling addiction lawsuit alleges claims including Strict Liability, Negligent Misrepresentation, and Fraudulent Concealment, and seeks damages for neuropsychiatric, mental, physical, and economic damages, as well as punitive damages

Lexi J. Hazam of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Rikki Carlson of Fall River, Massachusetts, has filed a personal injury lawsuit against Bristol-Myers Squibb Company, Otsuka Pharmaceutical Co., Ltd., and Otsuka America Pharmaceutical, Inc. (“Defendants”) for damages suffered as a direct and proximate result of Defendants’ wrongful conduct in connection with the development, design, testing, labeling, packaging, promoting, advertising, marketing, distribution, and selling of the blockbuster prescription drug Abilify.

[Read more…]

Risperdal Injury Trial Leads to $70 Million Verdict Against Johnson & Johnson in Pennsylvania

Risperdal gynecomastia injuries and lawsuits

Law360 reports (subscription) that Johnson & Johnson received a $70 million verdict on a Philadelphia Risperdal injury case where side effectsd of the widely-prescribed antipsychotic drug caused an adolescent boy to grow prominent breasts. This verdict is significantly higher than other recent Pennsylvania Risperdal injury judgments against J&T over allegations that the drug caused breast growth. [Read more…]

Pro Publica: Why Drug Testing’s Omission of Pregnant Women May Have Led to Zofran Birth Defect Injuries

California Parents File Zofran Lawsuit Against GlaxoSmithKline

Pro Publica has published a lengthy article exploring how the medical establishment’s long-standing approach to “protecting” fetuses by restricting testing on pregnant women has resulted in a critical shortfall of knowledge. While the intention was mostly good — to protect women and babies from the kind of severe birth defects and other harm caused by thalidomide and other drugs in the 1960s and ‘70s (but also to protect pharmaceutical companies from legal liability for those injuries) — the result is less certain. By excluding women — and pregnant women in particular — from clinical trials, doctors have been forced into prescribing untried medications “off-label” to pregnant women, with results that can lead to serious negative health consequences for mothers, and birth defects for babies. [Read more…]